Flo Health, MYNE, BoBo, and Meddenovo

Welcome to another edition of the Who Got Funded newsletter. 🚀 

My name is Onofre, and I'm an entrepreneur living in Aarhus, Denmark. Every week, I dedicate 3 to 4 hours of my free time to reading startup news, which I then summarize in this newsletter.

I hope you enjoy this content. Thank you so much for reading. ✌️ 

Estimated reading time: ⌛️ 4 min 50 sec.

SERIES B AND LATER
London-based femtech Flo Health secures more than €180 million Series C and achieves unicorn status

🇬🇧 Flo Health, one of the most downloaded women’s health apps worldwide, announced it has raised more than €180 million in a Series C round.

This milestone pushes Flo's valuation beyond $1 billion, making it the first purely digital women's health app to achieve 🦄 status. That’s impressive!

As of June 2024, this startup had nearly 70 million monthly active users and almost 5 million paying subscribers. Additionally, 1 in 4 women in the United States uses Flo’s app. A nice example of a very successful startup.

👉️ You can read more about this deal here.

More Series B (and later) interesting stories:

🇺🇸 Self-driving truck startup Aurora Innovation raises €442.3 million ahead of commercial launch.

🇩🇪 Mannheim-based Osapiens raises €110.7 million Series B to help companies navigate ESG regulation.

🇮🇹 Italian company Alps Blockchain, specializing in computational power for blockchain and digital mining, secures €105 million in debt.

🇬🇧 Healx, an AI-enabled drug discovery platform for rare diseases, raises €43 million.

🇩🇪 Berlin-based Checkly secures €18.4 million Series B to slash website downtime with 10x faster issue resolving.

🏴󠁧󠁢󠁳󠁣󠁴󠁿 Edinburgh-based Shot Scope raises €7.8 million Series B to make golfers improve their game.

SERIES A
Berlin-based MYNE raises €40 million to further scale co-ownership of premium vacation homes

🇩🇪 MYNE, one of Europe’s leading managed co-ownership provider for premium vacation homes, has secured €40 million in Series A funding through a mix of equity and debt.

According to the press release, this is the largest financing round in the European proptech sector so far in 2024. Very nice! 🚀 

This startup allows individuals to invest in premium vacation homes, starting from €50.000. By purchasing shares, you also gain the right to use the property for at least 6,5 weeks per year.

Additionally, co-owners can have all property maintenance taken care of for a monthly fee.

The startup, which offers holiday properties in six European countries, has raised over 60 million since its foundation in 2021.

👉️ You can read more about this deal here.

More Series A interesting stories:

🇧🇪 Brussels-based Credo AI raises €19.4 million to match the rapid pace of AI with responsible governance.

🇬🇧 London-based Female Invest bags €10.3 million Series A to be the largest finance app for women.

SEED
Vilnius-based BoBo secures €6.5 million to facilitate instant large volume cross-border transactions

🇱🇹 Bourgeois Boheme (BoBo), a fintech company for “the new generation of successful entrepreneurs”, closed a €6.5 million seed round.

This startup has a very clear idea of their customer segment: High-net-worth individuals (HNWIs) and their families.

They believe there is a growing demand for simplified high-volume cash flow management, and according to the Knight Frank Wealth Report 2024, this is accurate, as the number of HNWIs is projected to increase in the coming years.

👉️ You can read more about this deal here.

More Seed interesting stories:

🇬🇧 London-based Axle Energy raises €8.3 million for platform to decarbonise the power grid.

🏴󠁧󠁢󠁷󠁬󠁳󠁿 Cardiff-based travel platform Lovetovisit raises €3.8 million to champion local tourism.

🇪🇸 Barcelona-based Masterplace gets €1.85 million to address low completion rates in online courses with AI support.

🇳🇱 Dutch startup OpusFlow secures €1.7 million to streamline sustainable installers’ operations.

🏴󠁧󠁢󠁳󠁣󠁴󠁿 Edinburgh-based Chromacity raises €1.18 million to roll out healthcare-focused ultrafast laser.

PRE-SEED
Meddenovo secures €1 million to unlock cyclic peptides' drug development potential

🇫🇷 Meddenovo, a provider of drug design through AI and molecular modelling, has announced a €1 million pre-seed round.

This company specializes in something called “cyclic peptides”, which are small chains of amino acids that form a loop or ring structure. Unlike regular peptides, which have two ends, cyclic peptides are connected end-to-end, forming a closed circle.

If, like me, you're not familiar with “bio” terminology, here's a simpler explanation: this startup is speeding up pharmaceutical research by using AI to design new drugs, specifically focusing on cyclic peptides.

👉️ You can read more about this deal here.

More pre-Seed interesting stories:

🇳🇱 Amsterdam-based Epum raises a €1.47 million to reinvent commercial real estate development research.

🇬🇧 London-based Stairpay raises €890k to automate the entire shared ownership journey.